Angiotensin II type 1 receptor autoantibody blockade improves cerebral blood flow autoregulation and hypertension in a preclinical model of preeclampsia

References

• Hammer ES, Cipolla MJ. Cerebrovascular dysfunction in preeclamptic pregnancies. Curr Hypertens Rep. 2015;17(8):64.
   PubMed Web of Science ®Google Scholar
• Paul BS, Juneja SK, Paul G, et al. Spectrum of neurological complications in HELLP syndrome. Neurol India. 2013;61(5):467–471.
   PubMed Web of Science ®Google Scholar
• Zunker P, Ley-Pozo J, Louwen F, et al. Cerebral hemodynamics in pre-eclampsia/eclampsia syndrome. Ultrasound Obstetrics Gynecol. 1995;6(6):411–415.
   PubMed Web of Science ®Google Scholar
• Chutatape A, Teoh WH. Third nerve palsy associated with preeclampsia and HELLP syndrome. J Anesth. 2013;27(5):757–760.
   PubMed Web of Science ®Google Scholar
• Cunningham MW Jr., LaMarca B. Risk of cardiovascular disease, end-stage renal disease, and stroke in postpartum women and their fetuses after a hypertensive pregnancy. Am J Physiol Regul Integr Comp Physiol. 2018;315(3):R521–R528.
   PubMed Web of Science ®Google Scholar
• Cipolla MJ. Cerebrovascular function in pregnancy and eclampsia. Hypertension. 2007;50(1):14–24.
   PubMed Web of Science ®Google Scholar
• Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 1973;52(11):2682–2689.
   PubMed Web of Science ®Google Scholar
• Brewer J, Owens MY, Wallace K, et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol. 2013;208(6):468e461–466. .
   Web of Science ®Google Scholar
• Cunningham FG, Twickler D. Cerebral edema complicating eclampsia. Am J Obstet Gynecol. 2000;182(1 Pt 1):94–100.
   PubMed Web of Science ®Google Scholar
• van Veen TR, Panerai RB, Haeri S, et al. Cerebral autoregulation in normal pregnancy and preeclampsia. Obstet Gynecol. 2013;122(5):1064–1069.
   PubMed Web of Science ®Google Scholar
• van Veen TR, Panerai RB, Haeri S, et al. Cerebral autoregulation in different hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2015;212(4):513e511–517. .
   Web of Science ®Google Scholar
• Jones-Muhammad M, Warrington JP. Cerebral blood flow regulation in pregnancy, hypertension, and hypertensive disorders of pregnancy. Brain Sci. 2019;9(9):9.
   Web of Science ®Google Scholar
• Warrington JP, Fan F, Murphy SR, et al. Placental ischemia in pregnant rats impairs cerebral blood flow autoregulation and increases blood-brain barrier permeability. Physiol Rep. 2014;2(8):8.
   Google Scholar
• Cunningham MW Jr., Williams JM, Amaral L, et al. Agonistic autoantibodies to the angiotensin II type 1 receptor enhance angiotensin II-induced renal vascular sensitivity and reduce renal function during pregnancy. Hypertension. 2016;68(5):1308–1313. .
   PubMed Web of Science ®Google Scholar
• Warrington JP, Fan F, Duncan J, et al. The angiotensin II type I receptor contributes to impaired cerebral blood flow autoregulation caused by placental ischemia in pregnant rats. Biol Sex Differ. 2019;10(1):58. .
   PubMed Web of Science ®Google Scholar
• Vaka VR, Cunningham MW, Deer E, et al. Blockade of endogenous angiotensin II type I receptor agonistic autoantibody activity improves mitochondrial reactive oxygen species and hypertension in a rat model of preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2020;318(2):R256–R262. .
   PubMed Web of Science ®Google Scholar
• Cunningham MW Jr., Vaka VR, McMaster K, et al. Renal natural killer cell activation and mitochondrial oxidative stress; new mechanisms in AT1-AA mediated hypertensive pregnancy. Pregnancy Hypertens. 2019;15:72–77.
   PubMed Web of Science ®Google Scholar
• Campbell N, LaMarca B, Cunningham MW Jr. The role of agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pathophysiology of preeclampsia. Curr Pharm Biotechnol. 2018;19(10):781–785.
   PubMed Web of Science ®Google Scholar
• Cunningham MW Jr., Castillo J, Ibrahim T, et al. AT1-AA (angiotensin II type 1 receptor agonistic autoantibody) blockade prevents preeclamptic symptoms in placental ischemic rats. Hypertension. 2018;71(5):886–893.
   PubMed Web of Science ®Google Scholar
• Wallukat G, Neichel D, Nissen E, et al. Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia. Can J Physiol Pharmacol. 2003;81(2):79–83.
   PubMed Web of Science ®Google Scholar
• Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103(7):945–952. .
   PubMed Web of Science ®Google Scholar
• Granger JP, LaMarca BB, Cockrell K, et al. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med. 2006;122:383–392.
   PubMedGoogle Scholar
• Lu F, Bytautiene E, Tamayo E, et al. Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol. 2007;197(4):418e411–415. .
   Web of Science ®Google Scholar
• Studer J, Bartsch C, Haas C. Aquaporin-4 polymorphisms and brain/body weight ratio in sudden infant death syndrome (SIDS). Pediatr Res. 2014;76(1):41–45.
   PubMed Web of Science ®Google Scholar
• Lamarca B. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia. Minerva Ginecol. 2012;64(4):309–320.
   PubMedGoogle Scholar
• Shah DA, Khalil RA. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia. Biochem Pharmacol. 2015;95(4):211–226.
   PubMed Web of Science ®Google Scholar
• Zeeman GG, Fleckenstein JL, Twickler DM, et al. Cerebral infarction in eclampsia. Am J Obstet Gynecol. 2004;190(3):714–720.
   PubMed Web of Science ®Google Scholar
• Fantini S, Sassaroli A, Tgavalekos KT, et al. Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive optical methods. Neurophotonics. 2016;3(3):031411.
   PubMed Web of Science ®Google Scholar
• Eames PJ, Blake MJ, Dawson SL, et al. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2002;72(4):467–472.
   PubMed Web of Science ®Google Scholar
• Gschwend S, Henning RH, Pinto YM, et al. Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. Br J Pharmacol. 2003;139(7):1317–1325.
   PubMed Web of Science ®Google Scholar
• Koobi P, Kalliovalkama J, Jolma P, et al. AT1 receptor blockade improves vasorelaxation in experimental renal failure. Hypertension. 2003;41(6):1364–1371.
   PubMed Web of Science ®Google Scholar
• Brewer J, Liu R, Lu Y, et al. Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy. Hypertension. 2013;62(5):886–892.
   PubMed Web of Science ®Google Scholar
• Herse F, LaMarca B. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am J Reprod Immunol. 2013;69(4):413–418.
   PubMed Web of Science ®Google Scholar
• Soma-Pillay P, Suleman FE, Makin JD, et al. Cerebral white matter lesions after pre-eclampsia. Pregnancy Hypertens. 2017;8:15–20.
   PubMed Web of Science ®Google Scholar
• Postma IR, Bouma A, de Groot JC, et al. Cerebral white matter lesions, subjective cognitive failures, and objective neurocognitive functioning: A follow-up study in women after hypertensive disorders of pregnancy. J Clin Exp Neuropsychol. 2016;38(5):585–598.
   PubMed Web of Science ®Google Scholar
• Garry PS, Ezra M, Rowland MJ, et al. The role of the nitric oxide pathway in brain injury and its treatment–from bench to bedside. Exp Neurol. 2015;263:235–243.
   PubMed Web of Science ®Google Scholar
• Khatri N, Thakur M, Pareek V, et al. Oxidative stress: major threat in traumatic brain injury. CNS Neurol Disord Drug Targets. 2018;17(9):689–695.
   PubMed Web of Science ®Google Scholar
• Gemma C, Vila J, Bachstetter A, et al. Oxidative stress and the aging brain: from theory to prevention. In: Riddle DR, editor Brain aging: models, methods, and mechanisms. Boca Raton (FL): 2007.
   Google Scholar
• Faraci FM. Protecting the brain with eNOS: run for your life. Circ Res. 2006;99(10):1029–1030.
   PubMed Web of Science ®Google Scholar
• Amaral LM, Cornelius DC, Harmon A, et al. 17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension. 2015;65(1):225–231.
   PubMed Web of Science ®Google Scholar
• Duchemin S, Boily M, Sadekova N, et al. The complex contribution of NOS interneurons in the physiology of cerebrovascular regulation. Front Neural Circuits. 2012;6:51.
   PubMed Web of Science ®Google Scholar
• Toyoda K, Fujii K, Ibayashi S, et al. Role of nitric oxide in regulation of brain stem circulation during hypotension. J Cereb Blood Flow Metab. 1997;17(10):1089–1096.
   PubMed Web of Science ®Google Scholar
• Santizo R, Baughman VL, Pelligrino DA. Relative contributions from neuronal and endothelial nitric oxide synthases to regional cerebral blood flow changes during forebrain ischemia in rats. Neuroreport. 2000;11(7):1549–1553.
   PubMed Web of Science ®Google Scholar
• Raijmakers MT, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension. 2004;44(4):374–380.
   PubMed Web of Science ®Google Scholar
• Moretti M, Phillips M, Abouzeid A, et al. Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia. Am J Obstet Gynecol. 2004;190(5):1184–1190.
   PubMed Web of Science ®Google Scholar
• Abdul-Muneer PM, Chandra N, Haorah J. Interactions of oxidative stress and neurovascular inflammation in the pathogenesis of traumatic brain injury. Mol Neurobiol. 2015;51(3):966–979.
   PubMed Web of Science ®Google Scholar
• Ayer RE, Zhang JH. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl. 2008;104:33–41.
   PubMedGoogle Scholar
• Drummond GR, Selemidis S, Griendling KK, et al. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov. 2011;10(6):453–471.
   PubMed Web of Science ®Google Scholar
• Qin F, Simeone M, Patel R. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction. Free Radic Biol Med. 2007;43(2):271–281.
   PubMed Web of Science ®Google Scholar
• Sedeek M, Gilbert JS, LaMarca BB, et al. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens. 2008;21(10):1152–1156.
   PubMed Web of Science ®Google Scholar
• Vaka VR, McMaster KM, Cunningham MW Jr., et al. Role of mitochondrial dysfunction and reactive oxygen species in mediating hypertension in the reduced uterine perfusion pressure rat model of preeclampsia. Hypertension. 2018;72(3):703–711.
   PubMed Web of Science ®Google Scholar
• Diep QN, Amiri F, Touyz RM, et al. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension. 2002;40(6):866–871.
   PubMed Web of Science ®Google Scholar
• Chabrashvili T, Kitiyakara C, Blau J, et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol. 2003;285(1):R117–124.
   PubMed Web of Science ®Google Scholar
• Prusty SK, Sahu PK, Subudhi BB. Angiotensin mediated oxidative stress and neuroprotective potential of antioxidants and AT1 receptor blockers. Mini Rev Med Chem. 2017;17(6):518–528.
   PubMed Web of Science ®Google Scholar
• Modrick ML, Didion SP, Sigmund CD, et al. Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging. Am J Physiol Heart Circ Physiol. 2009;296(6):H1914–1919.
   PubMed Web of Science ®Google Scholar
• Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86(5):494–501.
   PubMed Web of Science ®Google Scholar
• Jung KH, Chu K, Lee ST, et al. Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. J Pharmacol Exp Ther. 2007;322(3):1051–1058.
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Xu T, Johren O, et al. The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression. Basic Res Cardiol. 1998;93(Suppl 2):63–68.
   PubMedGoogle Scholar
• Mattos JD, Campos MO, Rocha MP, et al. Human brain blood flow and metabolism during isocapnic hyperoxia: the role of reactive oxygen species. J Physiol. 2019;597(3):741–755. .
   PubMed Web of Science ®Google Scholar